| TMP001 in Relapsing-remitting Multiple Sclerosis (NCT02686788) | Dr. Frank Behrens | 2015-08-01 |
| A Study of SM04554 Applied Topically to the Scalp of Male Subjects With Androgenetic Alopecia Analyzed by Biopsy of the Scalp Prior To and Post Dosing (NCT02503137) | Biosplice Therapeutics, Inc. | 2015-08-01 |
| Study of Stereotactic Body Radiation Therapy for Patients After Radical Resection of Pancreatic Cancer With Advanced Stages (T3 or N1) (NCT02461836) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2015-08-01 |
| Nicotinic Treatment of Post-Chemotherapy Subjective Cognitive Impairment: A Pilot Study (NCT02312934) | Vanderbilt University Medical Center | 2015-08-01 |
| A Study by the Tracking Resistance to Artemisinin Collaboration (TRAC) (NCT02453308) | University of Oxford | 2015-08-01 |
| Hippocampal-Sparing Prophylactic Cranial Irradiation in Pathologically Nodal Positive Non-Small-Cell Lung Cancer (NCT02448992) | Chang Gung Memorial Hospital | 2015-08-01 |
| Effectiveness of Ranolazine on Reducing Chest Pain in Patients With Blockage But no Stents (NCT02147834) | North Florida Foundation for Research and Education | 2015-08-01 |
| Proton Radiotherapy for Primary Central Nervous System Tumours in Adults (NCT02797366) | Uppsala University | 2015-08-01 |
| Investigating the Microstructural and Functional Alterations of Brain in Parkinson's Disease Patients (NCT02599753) | Chang Gung Memorial Hospital | 2015-08-01 |
| Local Ketamine Instillation for Postoperative Analgesia (NCT02642497) | Assiut University | 2015-08-01 |
| Hyperthermy Endocavitary Treatment in Pelvic Pain (NCT02837588) | Universidad Rey Juan Carlos | 2015-08-01 |
| Quantitating the Impact of Plerixafor (NCT02522572) | E. Steve Woodle | 2015-08-01 |
| An Exploratory Safety and Immunogenicity Study of HPV16+ Immunotherapy VB10.16 in Women With HSIL; CIN 2/3) (NCT02529930) | Nykode Therapeutics ASA | 2015-08-01 |
| Clinical Trial to Study the Safety and Tolerability of Memantin Mepha® in Sickle Cell Disease Patients (NCT02615847) | University of Zurich | 2015-08-01 |
| A Multi-center Study of Low-dose Decitabine for the Treatment of Immune Thrombocytopenia (NCT01568333) | Shandong University | 2015-08-01 |
| Study of Varying Injection Schedules of TDENV-PIV Vaccine With AS03B Adjuvant and Placebo in Healthy US Adults (NCT02421367) | U.S. Army Medical Research and Development Command | 2015-08-01 |
| Allogeneic Hematopoietic Stem Cell Transplantation With Ixazomib for High Risk Multiple Myeloma (BMT CTN 1302) (NCT02440464) | National Heart, Lung, and Blood Institute (NHLBI) | 2015-08-01 |
| Evaluation of ARI-3037MO, to Suppress LDL Cholesterol in Patients With Dyslipidemia (NCT02532218) | Arisaph Pharmaceuticals Inc | 2015-08-01 |
| The Effect of Rosuvastatin and Olmesartan on the Progression of Coronary Atherosclerotic Disease (NCT02516826) | Samsung Medical Center | 2015-08-01 |
| Tauroursodeoxycholic Acid (TUDCA) in New-Onset Type 1 Diabetes (NCT02218619) | Robin Goland, MD | 2015-08-01 |
| CER-001 Atherosclerosis Regression ACS Trial (NCT02484378) | Cerenis Therapeutics, SA | 2015-08-01 |
| Efficacy and Safety of Prurisol Administered Orally for Active Mild to Moderate Chronic Plaque Psoriasis (NCT02494479) | Cellceutix Corporation | 2015-08-01 |
| Nicotinic Receptors and Schizophrenia (NCT02538081) | VA Office of Research and Development | 2015-08-01 |
| Botulinum Toxin-A as a Treatment for Chronic Muscle-Related Pain in Adults With Spastic Cerebral Palsy: a Randomized Controlled Trial (NCT02434549) | Kristina Tedroff | 2015-08-01 |
| Fiber and Water Improve Bowel Habit in Humans (NCT02838849) | Universidade de Passo Fundo | 2015-08-01 |
| Small Volume Simethicone Before Gastroscopy: Any Benefit? (NCT02555228) | Changi General Hospital | 2015-08-01 |
| Baby Vaccine Study (Sched3) (NCT02482636) | University of Oxford | 2015-08-01 |
| Study of Neo-adjuvant Use of Vemurafenib Plus Cobimetinib for BRAF Mutant Melanoma With Palpable Lymph Node Metastases (NCT02036086) | Sunnybrook Health Sciences Centre | 2015-08-01 |
| Ixazomib, Cyclophosphamide and Dexamethasone for Multiple Myeloma (NCT02412228) | John L. Reagan | 2015-08-01 |
| Efficacy and Safety of Lidocaine Infusion Treatment in Management of Neuropathic Pain (NCT02597257) | Seoul National University Hospital | 2015-08-01 |
| Efficacy of Anthocyanin Mouthrinse for Oral Anti-inflammation From Orthodontic Treatment (NCT02536781) | Khon Kaen University | 2015-08-01 |
| Study of ARC-520 in Participants With Hepatitis B Virus e Antigen (HBeAg) Positive Chronic Hepatitis B Virus (NCT02452528) | Arrowhead Pharmaceuticals | 2015-08-01 |
| Progesterone Supplementation for HIV-positive Pregnant Women on Anti-Retrovirals (NCT02400021) | Mount Sinai Hospital, Canada | 2015-08-01 |
| A Study of Cabazitaxel for Patients With Breast or Lung Cancer and Recurrent or Progressive Brain Metastases - Cabazitaxel for Brain Metastases (CaBaMet) (NCT02166658) | AIO-Studien-gGmbH | 2015-08-01 |
| Study of NGM282 in Patients With Nonalcoholic Steatohepatitis (NASH) (NCT02443116) | NGM Biopharmaceuticals, Inc | 2015-07-31 |
| Rituximab and Pembrolizumab With or Without Lenalidomide in Treating Patients With Relapsed Follicular Lymphoma and Diffuse Large B-Cell Lymphoma (NCT02446457) | M.D. Anderson Cancer Center | 2015-07-31 |
| Continuing Treatment for Subjects Who Have Participated on a Prior Protocol Investigating Dasatinib (NCT02297139) | Bristol-Myers Squibb | 2015-07-31 |
| Evaluation of Safety, Efficacy, Pharmacokinetic and Pharmacodynamic of Bertilimumab in Patients With Active Moderate to Severe Ulcerative Colitis (NCT01671956) | Alexion Pharmaceuticals, Inc. | 2015-07-31 |
| Trial of Topotecan With VX-970 (M6620), an ATR Kinase Inhibitor, in Small Cell Cancers and Extrapulmonary Small Cell Cancers (NCT02487095) | National Cancer Institute (NCI) | 2015-07-30 |
| A Study to Evaluate the Safety of Lebrikizumab Compared to Topical Corticosteroids in Adult Patients With Atopic Dermatitis (NCT02465606) | Hoffmann-La Roche | 2015-07-30 |
| Treatment of Chronic Delta Hepatitis With Lonafarnib and Ritonavir (NCT02511431) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2015-07-29 |
| Safety and Efficacy of Sofosbuvir/Velpatasvir/Voxilaprevir Fixed-Dose Combination With or Without Ribavirin in Participants With Chronic Genotype 1 HCV Infection Previously Treated With a Direct Acting Antiviral Regimen (NCT02536313) | Gilead Sciences | 2015-07-29 |
| mFOLFOX vs. mFOLFIRI in Advanced or Recurrent Biliary Tract Cancer Refractory to First Line (NCT03464968) | Seoul National University Bundang Hospital | 2015-07-29 |
| A Double-blind Study of Paclitaxel in Combination With Reparixin or Placebo for Metastatic Triple-Negative Breast Cancer (NCT02370238) | Dompé Farmaceutici S.p.A | 2015-07-29 |
| Study of Efficacy and Safety of CTL019 in Adult DLBCL Patients (NCT02445248) | Novartis Pharmaceuticals | 2015-07-29 |
| Remodulin as Add-on Therapy for the Treatment of Persistent Pulmonary Hypertension of the Newborn (NCT02261883) | United Therapeutics | 2015-07-29 |
| Mechanism of Allogeneic UCB Therapy in Cerebral Palsy (NCT03130816) | Bundang CHA Hospital | 2015-07-29 |
| Phase 2a RDEA3170 and Allopurinol Combination Study in Gout Subjects (NCT02498652) | Ardea Biosciences, Inc. | 2015-07-28 |
| Safety and Efficacy of Bevacizumab in Combination With Carboplatin and Paclitaxel for Metastatic, Recurrent or Persistent Cervical Cancer (NCT02467907) | Hoffmann-La Roche | 2015-07-28 |
| Treatment for Adductor Spasmodic Dysphonia by Type 2 Thyroplasty Using Titanium Bridges (NCT02528006) | Kumamoto University | 2015-07-27 |
| Phase II Safety and Efficacy Study of Oral ORMD-0801 in Patients With Type 2 Diabetes Mellitus (NCT02496000) | Oramed, Ltd. | 2015-07-27 |
| Study to Evaluate Efficacy, Safety and Tolerability of JNJ-42847922 in Participants With Insomnia Disorder Without Psychiatric Comorbidity (NCT02464046) | Janssen Research & Development, LLC | 2015-07-27 |
| A Preliminary Study of the Efficacy and Safety of MK-8521 for Type 2 Diabetes (MK-8521-004) (NCT02492763) | Merck Sharp & Dohme LLC | 2015-07-27 |
| A Phase 1/2, Open-label, Dose Finding Study to Evaluate CC-122 in Combination With Ibrutinib and Obinutuzumab in Subjects With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (NCT02406742) | Celgene | 2015-07-27 |
| Monitoring and Mapping of Erectile Nerve During RALP (MMEN Study) (NCT02507427) | Seoul National University Hospital | 2015-07-26 |
| To Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetics of a Single Dose Regimen of Ferroquine and Artefenomel in Adults and Children With Uncomplicated Plasmodium Falciparum Malaria (NCT02497612) | Sanofi | 2015-07-25 |
| Pharmacokinetic Study of the Association of Amoxicillin / Clavulanic Acid to Obese Adults (NCT02571959) | Institut de Médecine et d'Epidémiologie Appliquée - Fondation Internationale Léon M'Ba | 2015-07-24 |
| Intravitreal Ranibizumab (Lucentis®) in the Treatment of Non-leaking Macular Cysts in Retinal Dystrophy (NCT03763227) | Sultan Qaboos University | 2015-07-24 |
| Cytotoxic T Lymphocytes in Treating Patients With Malignancies With BK and/or JC Virus (NCT02479698) | M.D. Anderson Cancer Center | 2015-07-23 |
| Study of Recombinant Factor VIIa Fusion Protein (rVIIa-FP, CSL689) for On-demand Treatment of Bleeding Episodes in Patients With Hemophilia A or B With Inhibitors (NCT02484638) | CSL Behring | 2015-07-23 |
| A Pilot Study Comparing the Immunogenicity of Fendrix vs. Double-dose Engerix B in HIV-infected Non-responders to Standard Hepatitis B Vaccination Courses (NCT02434848) | Sheffield Teaching Hospitals NHS Foundation Trust | 2015-07-23 |
| An Efficacy and Safety Study of Sirukumab in Participants With Major Depressive Disorder (NCT02473289) | Janssen Research & Development, LLC | 2015-07-23 |
| Study to Evaluate the Efficacy and Safety of GSK3196165 Plus Methotrexate in Subjects With Active Moderate-Severe Rheumatoid Arthritis (NCT02504671) | GlaxoSmithKline | 2015-07-23 |
| Mechanisms of Refractory Hypertension (Reserpine) (NCT03223272) | University of Alabama at Birmingham | 2015-07-23 |
| Safety Tolerability and Efficacy of Intravitreal LMG324 in the Treatment of Neovascular Age-Related Macular Degeneration (NCT02398500) | Alcon Research | 2015-07-22 |
| A 24-week Off-drug Extension Study in Sarcopenic Elderly Who Completed Treatment in the 6-month Core Study (NCT02468674) | Novartis Pharmaceuticals | 2015-07-22 |
| A Trial of Lenvatinib (E7080) Plus Pembrolizumab in Participants With Selected Solid Tumors (NCT02501096) | Eisai Inc. | 2015-07-22 |
| ABT-199 & Ibrutinib in Mantle Cell Lymphoma (AIM) (NCT02471391) | Peter MacCallum Cancer Centre, Australia | 2015-07-22 |
| A Study of Donafenib Monotherapy in Advanced Oesophageal Cancer (NCT02489201) | Suzhou Zelgen Biopharmaceuticals Co.,Ltd | 2015-07-21 |
| Avatar-Directed Chemotherapy in Treating Patients With Ovarian, Primary Peritoneal, or Fallopian Tube Cancer (NCT02312245) | Mayo Clinic | 2015-07-21 |
| A Study in Asthma Patients to Evaluate Efficacy, Safety and Tolerability of 14 Days Once Daily Inhaled Interferon Beta-1a After the Onset of Symptoms of an Upper Respiratory Tract Infection (NCT02491684) | AstraZeneca | 2015-07-21 |
| Regorafenib in Subjects With Antiangiogenic-naive and Chemotherapy-refractory Advanced Colorectal Cancer (NCT02465502) | Bayer | 2015-07-21 |
| Evaluation of Intravesical LP08 in Patients With Interstitial Cystitis/Painful Bladder Syndrome (NCT01393223) | Lipella Pharmaceuticals, Inc. | 2015-07-21 |
| Study of UX003 Recombinant Human Beta-Glucuronidase (rhGUS) Enzyme Replacement Treatment in Mucopolysaccharidosis Type 7, Sly Syndrome (MPS 7) Patients Less Than 5 Years of Age (NCT02418455) | Ultragenyx Pharmaceutical Inc | 2015-07-21 |
| Nivolumab in Treating Patients With Recurrent and/or Metastatic Nasopharyngeal Cancer (NCT02339558) | National Cancer Institute (NCI) | 2015-07-21 |
| Everolimus Therapy in People With Birt-Hogg-Dube Syndrome (BHD)-Associated Kidney Cancer or Sporadic Chromophobe Renal Cancer (NCT02504892) | National Cancer Institute (NCI) | 2015-07-21 |
| MK-3475 and Gemcitabine in Non-Small Cell Lung Cancer (NSCLC) (NCT02422381) | Providence Health & Services | 2015-07-20 |
| A Study to Assess the Tolerability of a Single Dose of Gefapixant (AF-219/MK-7264) in Subjects With Idiopathic Pulmonary Fibrosis (IPF) (NCT02477709) | Afferent Pharmaceuticals, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 2015-07-20 |
| A Study of Ad-RTS-hIL-12 With Veledimex in Subjects With Breast Cancer (NCT02423902) | Alaunos Therapeutics | 2015-07-18 |
| Rituximab Plus Corticosteroids in Non-infectious Active Mixed Cryoglobulinemia Vasculitis (NCT02556866) | Assistance Publique - Hôpitaux de Paris | 2015-07-17 |
| ORION: Effects of Cenicriviroc on Insulin Sensitivity in Subjects With Prediabetes or Type 2 Diabetes Mellitus (T2DM) and Suspected NAFLD (NCT02330549) | Tobira Therapeutics, Inc. | 2015-07-17 |
| Cisplatin Plus Romidepsin & Nivolumab in Locally Recurrent or Metastatic Triple Negative Breast Cancer (TNBC) (NCT02393794) | Priyanka Sharma | 2015-07-17 |
| Study of Propranolol to Decrease Gene Expression of Stress-Mediated Beta-Adrenergic Pathways in HCT Recipients (NCT02420223) | Medical College of Wisconsin | 2015-07-17 |
| Bendamustine Study in Classical Hodgkin Lymphoma Patients Over 60 Treated by Prednisone, Vinblastine and Doxorubicin (NCT02414568) | The Lymphoma Academic Research Organisation | 2015-07-17 |
| Proof of Concept Study to Evaluate Safety and Efficacy of LME636 in the Treatment of Acute Anterior Uveitis (NCT02482129) | Alcon Research | 2015-07-17 |
| RRx-001 in Second Line Treatment of Advanced Cholangiocarcinoma Prior to Readministration of First-Line Therapy (NCT02452970) | EpicentRx, Inc. | 2015-07-16 |
| A Study To Investigate Two 3-dose Schedules Of A Clostridium Difficile Vaccine In Healthy Adults Aged 65 to 85 Years (NCT02561195) | Pfizer | 2015-07-16 |
| A Study of Atezolizumab in Advanced Solid Tumors (NCT02458638) | Hoffmann-La Roche | 2015-07-16 |
| Dose-finding Study of QGE031 as add-on Therapy to Evaluate Efficacy and Safety in Patients With CSU (NCT02477332) | Novartis Pharmaceuticals | 2015-07-15 |
| Ruxolitinib Phosphate or Dasatinib With Chemotherapy in Treating Patients With Relapsed or Refractory Philadelphia Chromosome-Like Acute Lymphoblastic Leukemia (NCT02420717) | M.D. Anderson Cancer Center | 2015-07-15 |
| Accelerated Partial Breast Radiation Therapy Using High-Dose Rate Brachytherapy in Treating Patients With Early Stage Breast Cancer After Surgery (NCT02526498) | Rutgers, The State University of New Jersey | 2015-07-15 |
| Rapamycine vs Placebo for the Treatment of Inclusion Body Myositis (NCT02481453) | Institut National de la Santé Et de la Recherche Médicale, France | 2015-07-15 |
| Carfilzomib for the Treatment of Patients With Advanced Neuroendocrine Cancers (NCT02318784) | SCRI Development Innovations, LLC | 2015-07-15 |
| The Transfusion Triggers in Vascular Surgery Trial (NCT02465125) | Naestved Hospital | 2015-07-15 |
| Neoadjuvant Study Using Trastuzumab or Trastuzumab With Pertuzumab in Gastric or Gastroesophageal Junction Adenocarcinoma (NCT02205047) | European Organisation for Research and Treatment of Cancer - EORTC | 2015-07-15 |
| A Study to Evaluate the Safety and Immunogenicity of a Candidate Ebola Vaccine in Adults (NCT02485301) | GlaxoSmithKline | 2015-07-15 |
| Phase 1-2 Study of ASTX660 in Subjects With Advanced Solid Tumors and Lymphomas (NCT02503423) | Taiho Oncology, Inc. | 2015-07-14 |
| PEGPH20, Gemicitabine and Nab-Paclitaxel for Pancreatic Ductal Adenocarcinoma (NCT02487277) | Andrew Ko | 2015-07-14 |
| Resveratrol and Cardiovascular Health in the Elderly (NCT01842399) | National Institute on Aging (NIA) | 2015-07-14 |
| Safety and Efficacy Study of Ulocuplumab and Nivolumab in Subjects With Solid Tumors (NCT02472977) | Bristol-Myers Squibb | 2015-07-13 |